Prognostic Markers for a Better Follow-up in Head and Neck Cancer.

Karolinska Institute

Status: Enrolling

Conditions: Head and Neck Cancer

Treatments: Genetic: DNA exome sequencing of tumor and blood

Study type: Observational

Funder types: Other

Identifiers

NCT06094985

2023-04222-01

Details and patient eligibility

About

To identify tumor specific DNA mutations and aberrations and to follow these in blood over time to predict treatment response/survival and secondly to correlate presence of these markers in blood to pathological parameters (LVI, Pn, WPOI and margins), radiological findings and to tumor stage.

Enrollment: 20 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patient diagnosed with head and neck cancer
• Treatment includes surgery
• Consent to participate

Exclusion criteria

• No consent
• Age below 18 years
• No surgery
• No tumor material to sample

Trial design

20 participants in 1 patient group

Patient with head and neck cancer

Description:

Patient diagnosed with head and neck cancer

Treatment:

Genetic: DNA exome sequencing of tumor and blood